Literature DB >> 19799889

Paraoxonase: a multifaceted biomolecule.

Binita Goswami1, Devika Tayal, Nikhil Gupta, V Mallika.   

Abstract

BACKGROUND: Paraoxonase enzyme was first identified as a protective barrier against organophosphorus poisoning. After painstaking research spanning the last three decades, the knowledge about this enzyme has increased immensely. The present review attempts to elaborate the role of paraoxonase enzyme in normal physiology as well as provide an overview of the various disorders in which the enzyme may have a role in etiopathogenesis.
METHODS: The literature was searched from the websites of the National Library of Medicine (http://www.ncbi.nlm.nih.gov/) and Pub Med Central, the U.S. National Library of Medicine's digital archive of life sciences journal literature.
RESULTS: Paraoxonase acts as an important antioxidant enzyme against oxidative stress. The enzyme has been implicated in the pathogenesis of a number of disorders including cardiovascular disorders, cancers etc.
CONCLUSIONS: A better understanding of the molecular mechanism of the enzyme along with the regulatory circuits will help us to utilize agonists to potentiate the anti oxidant actions of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799889     DOI: 10.1016/j.cca.2009.09.025

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  33 in total

1.  Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

Authors:  David O Osei-Hwedieh; Marcelo Amar; Dmitri Sviridov; Alan T Remaley
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

2.  Benefits of omega-3 Fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome.

Authors:  Elahe Mohammadi; Maryam Rafraf
Journal:  Health Promot Perspect       Date:  2012-12-28

3.  Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3.

Authors:  Hua Shen; Larry W Robertson; Gabriele Ludewig
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

4.  Epistasis between ADIPOQ rs1501299 and PON1 rs662 polymorphisms is potentially associated with the development of knee osteoarthritis.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Yessica Zamudio-Cuevas; Karina Martínez-Flores; Rolando Espinosa-Morales
Journal:  Mol Biol Rep       Date:  2019-02-08       Impact factor: 2.316

5.  R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Authors:  Abdolkarim Mahrooz; Ghorban Gohari; Mohammad-Bagher Hashemi; Mehryar Zargari; Hadis Musavi; Mahmoud Abedini; Ahad Alizadeh
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 6.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

7.  A Comprehensive Study of Oxidative Stress in Tinnitus Patients.

Authors:  Mustafa Celik; İsmail Koyuncu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-07-27

Review 8.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

9.  Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study.

Authors:  Abdolkarim Mahrooz; Mohammad-Reza Rashidi; Mohammad Nouri
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

10.  Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.

Authors:  D Liao; H Yu; L Han; C Zhong; X Ran; D Wang; L Mo
Journal:  J Endocrinol Invest       Date:  2018-03-15       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.